Stockreport

BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium

BioRestorative Therapies, Inc.  (BRTX) 
NASDAQ:AMEX Investor Relations: biorestorative.com/content/investor-relations
PDF – New blinded preliminary safety and efficacy data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in podium presentation on November 13, 2024 – – D [Read more]